FHTX – foghorn therapeutics inc. (US:NASDAQ)
Stock Stats
News
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences [Yahoo! Finance]
Foghorn Therapeutics to Participate in Two Upcoming Investor Conferences
Foghorn Therapeutics Strengthens Financial Leadership with Appointment of Ryan Maynard as Chief Financial Officer
Foghorn Therapeutics (NASDAQ:FHTX) was given a new $12.00 price target on by analysts at Jefferies Financial Group Inc..
Foghorn Therapeutics to Participate in the Guggenheim Emerging Outlook: Biotech Summit
Form 4 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Form 3 Foghorn Therapeutics For: Feb 23 Filed by: Maynard Ryan D
Form 8-K Foghorn Therapeutics For: Feb 23
Form 4 Foghorn Therapeutics For: Feb 05 Filed by: GOTTSCHALK ADRIAN
Form 4 Foghorn Therapeutics For: Jan 30 Filed by: Costa Carlos
Top News Gainers
Top News Decliners
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.